Mitochondrial DNA mutations in the pathogenesis in the head and neck squamous cell carcinoma;Mutacje mitochondrialnego DNA w rozwoju nowotworów głowy i szyi

Otolaryngologia Polska

Volumn 62, Issue 2, 2008, Pages 158-164

  Pietka, Grzegorz ^a   Kukwa, Wojciech ^b   Bartnik, Ewa ^a   Ścińska, Anna ^b   Czarnecka, Anna M ^a,c  

^a UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Studium Medycyny Molekularnej AM   (Poland)

Author keywords

Head and neck neoplasms; Mitochondrial DNA; Reactive oxygen species; Squamous cell carcinoma

Indexed keywords

EID: 44349090410     PISSN: 00306657     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0030-6657(08)70233-6     Document Type: Article

References (50)

1. Sanderson RJ, Ironside JA. Squamous cell carcinomas of the head and neck. BMJ 2002; 325: 822-827.
2. Herrero R. Human papillomavirus and cancer of the upper aerodigestive tract. J Natl Cancer Inst Monogr 2003; 47-51.
3. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000; 36: 256-263.
4. Ha PK, Califano JA. The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med 2004; 15: 188-196.
5. Petruzzelli GJ. The biology of tumor invasion, angiogenesis and lymph node metastasis. ORL J Otorhinolaryngol Relat Spec 2000; 62: 178-185.
6. Chung CH, Levy S, Yarbrough WG. Clinical applications of genomics in head and neck cancer. Head Neck 2006; 28: 360-368.
7. Modica-Napolitano JS, Kulawiec M, Singh KK. Mitochondria and human cancer. Curr Mol Med 2007; 7: 121-131.
8. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, i wsp. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-465.
9. Miller FJ, Rosenfeldt FL, Zhang C, Linnane AW i Nagley P. Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age. Nucleic Acids Res 2003; 31: e61.
10. Fernandez-Silva P, Enriquez JA, Montoya J. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 2003; 88: 41-56.
11. Khrapko K, Coller HA, Andre PC, Li XC, Hanekamp JS, Thilly WG. Mitochondrial mutational spectra in human cells and tissues. Proc Natl Acad Sci USA 1997; 94: 13798-13803.
12. Zheng W, Khrapko K, Coller HA, Thilly WG, Copeland WC. Origins of human point mutations as DNA polymerase gamma-mediated errors. Mutat Res 2006; 599: 11-20.
13. Berg JM, Tymoczko JL, Stryer L. Biochemistry Wyd. 4. San Francisco: W.H. Freeman and Company; 2002: 491-524.
14. DiMauro S, Davidzon G. Mitochondrial DNA and disease. Ann Med 2005; 37: 222-232.
15. Wallace DC. Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J 2000; 139: S70-S85.
16. Warburg O. On the Origin of Cancer Cells. Science 123: 309-314.
17. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891-899.
18. Costello LC, Franklin RB. Why do tumour cells glycolyse?: from glycolysis through citrate to lipogenesis. Mol Cell Biochem 2005; 280: 1-8.
19. Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, Manfredi G, i wsp. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 2005; 65: 1655-1663.
20. Pallotti F, Baracca A, Hernandez-Rosa E, Walker WF, Solaini G, Lenaz G, i wsp. Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations. Biochem J 2004: 287-293.
21. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, i wsp. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2004; 102: 719-724.
22. Czarnecka AM, Golik P, Bartnik E. Mitochondrial DNA mutations in human neoplasia. J Appl Genet 2006; 47: 67-78.
23. Brandon M, Baldii P, Wallace DC. Mitochondrial mutations in cancer. Oncogene 2006; 25: 4647-4662.
24. Balaban RS, Nemotoi S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005; 120: 483-495.
25. Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S, i wsp. Serial Review: The Powerhouse Takse Control of the Cell: the Role of Mitochondria in Signal Transduction. Free Radic Biol Med 2004; 37: 755-767.
26. Pitkanen S, Robinson BH. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 1996; 98: 345-351.
27. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004; 7: 97-110.
28. Kirkinezos IG, Moraes CT. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 2001; 12: 449-457.
29. Basoah A, Matthews PM, Morten KJ. Rapid rates of newly synthesized mitochondrial protein degradation are significantly affected by the generation of mitochondrial free radicals. FEBS Lett 2005; 579: 6511-6517.
30. Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 2003; 31: 1441-1444.
31. Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006; 5: 14.
32. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 1996; 271(8): 4138-4142.
33. Parks D, Bolinger R, Mann K. Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA. Nucleic Acids Res 1997; 25: 1289-1295.
34. Ha PK, Tong BC, Westra WH, Sanchez-Cespedes M, Parella P, Zahurak M, i wsp. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin Cancer Res 2002; 8: 2260-2265.
35. Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, i wsp. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 2001; 61: 7015-7019.
36. Takebayashi S, Ogawa T, Jung KY, Muallem A, Mineta H, Fisher SG, i wsp. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res 2000; 60: 3397-3403.
37. Lievre A, Blons H, Houllier AM, Laccourreye O, Brasnu D, Beaune P, i wsp. Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma. Br J Cancer 2006; 94: 692-697.
38. Zhou S, Kassauei K, Cutler DJ, Kennedy GC, Sidransky D, Maitra A, i wsp. An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome. J Mol Diagn 2006; 8: 476-482.
39. Zhou S, Kachhap S, Sun W, Wu G, Chuang A, Poeta L, i wsp. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci USA 2007; 104: 7540-7545.
40. Prior SL, Griffiths AP, Baxter JM, Baxter PW, Hodder SC, Silvester KC, i wsp. Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis 2006; 27: 945-950.
41. Yoshida Y, Izumi H, Torigoe T, Ishiguchi H, Itoh H, Kang D, i wsp. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res 2003; 63: 3729-3734.
42. Kim MM, Clinger JD, Masayesva BG, Ha PK, Zahurak ML, Westra WH, i wsp. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res 2004; 10: 8512-8515.
43. Jiang WW, Masayesva B, Zahurak M, Carvalho AL, Rosenbaum E, Mambo E, i wsp. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin Cancer Res 2005; 11: 2486-2491.
44. Jiang WW, Rosenbaum E, Mambo E, Zahurak M, Masayesva B, Carvalho AL, i wsp. Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients. Clin Cancer Res 2006; 12: 1564-1569.
45. Dani MA, Dani SU, Lima SP, Martinez A, Rossi BM, Soares F, i wsp. Less Delta-mtDNA 4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet Mol Res 2004; 3: 395-409.
46. Poetsch M, Petersmann A, Lignitzi E, Kleist B. Relationship between mitochondrlal DNA instability, mitochondrial DNA large deletions, and nuclear microsatellite instability in head and neck squamous cell carcinomas. Diagn Mol Pathol 2004; 13: 26-32.
47. Czarnecka AM, Marino Gammazza A, Di Felice V, Zummo G, Cappello F. Cancer as a Mitochondriopathy. J Cancer Mol 2007; 3: 71-79.
48. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I, i wsp. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997; 15: 1573-1581.
49. Jackson MJ, Papa S, Bolanos J, Bruckdorfer R, Carlsen H, Elliott RM, i wsp. Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol Aspects Med 2002; 23: 209-285.
50. Kokoszka JE, Coskun P, Esposito LA, Wallace DC. Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci USA 2001; 98: 2278-2283.